image
Healthcare - Biotechnology - NASDAQ - US
$ 30.75
-0.646 %
$ 13.7 B
Market Cap
12.11
P/E
RPRX - COST OF REVENUE

Cost of Revenue RPRX - Royalty Pharma plc

image
561 M
LAST VALUE
393.77%
2 YEAR CAGR
32.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR